HOME >> MEDICINE >> NEWS
Adverse Drug Reactions Are Under Reported

(Under reporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational study)

In this week's BMJ Dr Richard Martin from the Drug Safety Research Unit at Southampton and colleagues from the School of Medicine at the University of Southampton report that general practitioners under-report suspected adverse drug reactions to newly marketed drugs to the Committee on Safety of Medicines. Severe and previously unknown adverse drug reactions to new products are more likely to be reported to the Committee. The authors believe that under-reporting and this bias in reporting needs to be addressed and that doctors should report all adverse reactions, however minor, that their patients have to drugs that have recently been launched onto the market, to enable effective postmarketing surveillance to take place.

Contact:
Dr Richard Martin, Clinical Research Fellow, Drug Safety Research Unit, Southampton


'"/>

Contact: Jill Shepherd
jshepher@bma.org.uk
+44(0)171 383 6529
BMJ-British Medical Journal
10-Jul-1998


Page: 1

Related medicine news :

1. Adverse drug events in nursing homes are far more common than previously identified
2. Adverse events among patients following discharge from hospital
3. More Evidence Of Possible Adverse Effects From New Hormone Use In Women With Heart Disease
4. Scientists To Prepare Advisory Report On Whats Been Learned About The Possible Adverse Health Effects of Electric Fields
5. Beware Of Adverse Drug Reactions
6. Premature Birth Sometimes Can Adversely Affect Infants Ties To Mother
7. New Concepts Proposed To Investigate Drug Reactions
8. Understanding how vulnerabilities may keep women in abusive relationships
9. From town planning to intimate sex: Understanding the risks in our lives
10. Understanding how prostaglandin prevents gut injury during radiation therapy
11. Undertreatment spurs new arrests among drug ofenders diverted under Californias Proposition 36

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... for human induced pluripotent stem (iPS) cells and other difficult to transfect cells, ... Cloning Medium. The PluriQ™ G9™ Gene Editing System is a complete ...
(Date:6/24/2016)... ... 2016 , ... Southern Illinois University School of Dental Medicine ... State Dental Society (ISDS) Foundation’s Mission of Mercy (MOM). They will host a ... , They expect to treat approximately 2,000 patients from Illinois, Missouri, ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... Supply Foundation, a not-for-profit organization responsible for clinical transfusion research programs and for ... for the Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) study. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 VolitionRx ... of Dr. Edward Futcher to the ... effective June 23, 2016.Dr. Futcher was also appointed ... Governance Committees.  As a non-executive member of the ... and strategic counsel to VolitionRx in connection with ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology:
Cached News: